Abstract (See the editorial commentary by Lange, on pages 801–802.) For individuals with
human immunodeficiency virus (HIV) infection to fully benefit from potent combination …

Background: In pharmacotherapy, the achievement of a target clinical outcome requires a
certain level of medication intake or adherence. Based on Haynes's early empirical …

Background: A benchmark of near-perfect adherence (≥ 95%) to antiretroviral therapy
(ART) is often cited as necessary for HIV viral suppression. However, given newer, more …

In HIV-1-infected individuals on currently recommended antiretroviral therapy (ART), viremia
is reduced to< 50 copies of HIV-1 RNA per milliliter, but low-level residual viremia appears …

Abstract Purpose of Review In this review, we present new developments in antiretroviral
adherence, focusing on pharmacological measures and real-time adherence monitoring. In …

This is a systematic review of eighty-two published studies investigating the impact of DSM-
IV mental disorders on combination antiretroviral therapy (cART) adherence and persistence …

Objective: The aim of the ADONE (ADherence to ONE pill) study was to verify the effect of a
reduced number of pills on adherence and quality of life (QoL) in HIV-infected patients on …

HIV infection remains a global and public health issue with the incidence increasing in some
countries. Despite the fact that combination antiretroviral therapy (cART) has decreased …

The need to achieve≥ 95% adherence to HAART for treatment effectiveness may be a
barrier for universal initiation at early stages of HIV. Using longitudinal data collected from …

A literature review of original research articles on adherence to antiretroviral therapy (ART)
in developed countries, covering January 2000 to June 2011, was conducted to determine if …